Literature DB >> 16099555

Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens.

Analia Berinstein1, Cecilia Vazquez-Rovere, Sebastian Asurmendi, Evangelina Gómez, Flavia Zanetti, Osvaldo Zabal, Alejandro Tozzini, Daniela Conte Grand, Oscar Taboga, Gabriela Calamante, Hebe Barrios, Esteban Hopp, Elisa Carrillo.   

Abstract

As a step towards developing a safe and effective edible vaccine against Newcastle disease virus (NDV), we have explored the use of plants genetically engineered to express viral proteins. We report the construction of transgenic potato plants expressing the genes coding for immunogenic proteins of NDV under the regulation of CaMV 35S promoter and its immunogenicity in mice. All mice receiving transgenic plant extracts in incomplete Freund adjuvant produced specific anti-NDV antibodies. Animals fed with transgenic leaves showed a specific response against NDV. Detection of IgA released from in vitro-cultured intestinal tissue fragments indicated the presence of IgA-secreting cells in the gut.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099555     DOI: 10.1016/j.vaccine.2005.06.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Root-preferential expression of Newcastle virus glycoproteins driven by NtREL1 promoter in tobacco hairy roots and evaluation of oral delivery in mice.

Authors:  Narges Arkian Boroujeni; Somayeh Behjat Khatouni; Mohammad Javad Motamedi; Shaghayegh Afraz; Mahyat Jafari; Ali-Hatef Salmanian
Journal:  Transgenic Res       Date:  2022-01-10       Impact factor: 2.788

2.  Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens.

Authors:  Silvina Chimeno Zoth; Evangelina Gómez; Juan Manuel Carballeda; Oscar Taboga; Elisa Carrillo; Analía Berinstein
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

3.  Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies.

Authors:  Octavio Guerrero-Andrade; Elizabeth Loza-Rubio; Teresa Olivera-Flores; Tamás Fehérvári-Bone; Miguel Angel Gómez-Lim
Journal:  Transgenic Res       Date:  2006-08       Impact factor: 3.145

Review 4.  Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives.

Authors:  Muhammad Bashir Bello; Khatijah Yusoff; Aini Ideris; Mohd Hair-Bejo; Ben P H Peeters; Abdul Rahman Omar
Journal:  Biomed Res Int       Date:  2018-08-05       Impact factor: 3.411

5.  Induction of Immune Response in Animal Model Using Recombinant Anti-NDV Vaccine.

Authors:  Amir Ghaffar Shahriari; Abdolreza Bagheri; Alireza Afsharifar; Maziar Habibi-Pirkoohi
Journal:  Iran J Biotechnol       Date:  2019-01-11       Impact factor: 1.671

Review 6.  Plant-made vaccines for humans and animals.

Authors:  Edward P Rybicki
Journal:  Plant Biotechnol J       Date:  2010-03-11       Impact factor: 9.803

Review 7.  Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.

Authors:  Doreen Manuela Floss; Dieter Falkenburg; Udo Conrad
Journal:  Transgenic Res       Date:  2007-04-14       Impact factor: 2.788

8.  Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine.

Authors:  Amir Ghaffar Shahriari; Ali Niazi; Maziar Habibi-Pirkoohi
Journal:  Clin Exp Vaccine Res       Date:  2021-09-30

Review 9.  Production of complex viral glycoproteins in plants as vaccine immunogens.

Authors:  Emmanuel Margolin; Ros Chapman; Anna-Lise Williamson; Edward P Rybicki; Ann E Meyers
Journal:  Plant Biotechnol J       Date:  2018-06-11       Impact factor: 9.803

10.  Sunflower seed oil containing ginseng stem-leaf saponins (E515-D) is a safe adjuvant for Newcastle disease vaccine.

Authors:  L Yuan; Y Wang; Z Li; X Ma; X Cui; X Chi; W Xu; S Hu
Journal:  Poult Sci       Date:  2020-07-24       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.